Perspective Therapeutics (CATX) Change in Inventory (2010 - 2024)
Perspective Therapeutics (CATX) reported Change in Inventory of $16000.0 for Q2 2024, up 200.0% on a YoY basis from $5333.3 in Q3 2023, and up 159.26% sequentially from -$27000.0 in Q1 2024.
Perspective Therapeutics (CATX) Change in Inventory (2010 - 2024) Analysis & Trends
Perspective Therapeutics (CATX) has 15 years of Change in Inventory data on file, last reported at $16000.0 in Q2 2024.
- For the quarter ending Q2 2024, Change in Inventory rose 200.0% year-over-year to $16000.0; the trailing twelve-month figure through Jun 2025 stood at $16000.0 (up 107.08% YoY), and the FY2023 full-year result was -$359000.0, down 117.99% from the prior year.
- Change in Inventory improved to $16000.0 in Q2 2024, from -$27000.0 in the prior quarter.
- In the past five years, Change in Inventory ranged from a high of $2.0 million in Q3 2022 to a low of -$1.3 million in Q4 2021.
- A 5-year average of $196588.2 and a median of $22000.0 in 2020 frame the typical range for Change in Inventory.
- Peak annual rise in Change in Inventory reached 1163.49% in 2021, while the deepest fall reached 5836.36% in 2021.
- Tracing CATX's Change in Inventory over 5 years: stood at $22000.0 in 2020, then tumbled by 5836.36% to -$1.3 million in 2021, then surged by 106.02% to $76000.0 in 2022, then sank by 234.21% to -$102000.0 in 2023, then jumped by 115.69% to $16000.0 in 2024.
- Business Quant data shows CATX's Change in Inventory at $16000.0 in Q2 2024, -$27000.0 in Q1 2024, and -$102000.0 in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 420.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 127.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | -399.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 177.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 1.60 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 65.20 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | -264.59 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 171.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Perspective Therapeutics | 146.05 Mn | 146.05 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | 16,000.00 |
| Jun 30, 2024 | 16,000.00 |
| Mar 31, 2024 | -27,000.00 |
| Mar 31, 2024 | -27,000.00 |
| Dec 31, 2023 | -102,000.00 |
| Dec 31, 2023 | -102,000.00 |
| Sep 30, 2023 | -113,000.00 |
| Sep 30, 2023 | -113,000.00 |
| Jun 30, 2023 | -16,000.00 |
| Jun 30, 2023 | -16,000.00 |
| Mar 31, 2023 | -128,000.00 |
| Mar 31, 2023 | -128,000.00 |
| Dec 31, 2022 | 76,000.00 |
| Dec 31, 2022 | 76,000.00 |
| Sep 30, 2022 | 2.02 Mn |
| Sep 30, 2022 | 2.02 Mn |
| Jun 30, 2022 | 1.92 Mn |
| Jun 30, 2022 | 1.92 Mn |
| Mar 31, 2022 | -84,000.00 |
| Mar 31, 2022 | -84,000.00 |